Biologiske behandlinger af andre dermatologiske sygdomme end psoriasis

Robert Gniadecki; Lone Skov

Biologiske behandlinger af andre dermatologiske sygdomme end psoriasis

Translated title of the contribution: Biologics in skin diseases other than psoriasis

Robert Gniadecki, Lone Skov

Abstract

Psoriasis is the only disease in dermatology where biologics have been studied in placebo controlled trials. However, drugs have been used for several other indications in dermatology, e.g. pyoderma gangrenosum and pemphigus. We give a brief overview of the indications for biologics in skin diseases.

Translated title of the contribution	Biologics in skin diseases other than psoriasis
Original language	Danish
Journal	Ugeskrift for Laeger
Volume	170
Issue number	24
Pages (from-to)	2126-8
Number of pages	3
ISSN	0041-5782
Publication status	Published - 9 Jun 2008

Cite this

@article{3f3ada4214cc447ab2f6add8eb822c8c,

title = "Biologiske behandlinger af andre dermatologiske sygdomme end psoriasis",

abstract = "Psoriasis is the only disease in dermatology where biologics have been studied in placebo controlled trials. However, drugs have been used for several other indications in dermatology, e.g. pyoderma gangrenosum and pemphigus. We give a brief overview of the indications for biologics in skin diseases.",

keywords = "Acne Vulgaris, Adalimumab, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Agents, Behcet Syndrome, Dermatologic Agents, Etanercept, Humans, Immunoglobulin G, Immunologic Factors, Infliximab, Interferons, Lymphoma, T-Cell, Cutaneous, Pemphigus, Pyoderma Gangrenosum, Receptors, Tumor Necrosis Factor, Rituximab, Skin Diseases, Skin Neoplasms",

author = "Robert Gniadecki and Lone Skov",

year = "2008",

month = jun,

day = "9",

language = "Dansk",

volume = "170",

pages = "2126--8",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "24",

}

TY - JOUR

T1 - Biologiske behandlinger af andre dermatologiske sygdomme end psoriasis

AU - Gniadecki, Robert

AU - Skov, Lone

PY - 2008/6/9

Y1 - 2008/6/9

N2 - Psoriasis is the only disease in dermatology where biologics have been studied in placebo controlled trials. However, drugs have been used for several other indications in dermatology, e.g. pyoderma gangrenosum and pemphigus. We give a brief overview of the indications for biologics in skin diseases.

AB - Psoriasis is the only disease in dermatology where biologics have been studied in placebo controlled trials. However, drugs have been used for several other indications in dermatology, e.g. pyoderma gangrenosum and pemphigus. We give a brief overview of the indications for biologics in skin diseases.

KW - Acne Vulgaris

KW - Adalimumab

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Antibodies, Monoclonal, Murine-Derived

KW - Antineoplastic Agents

KW - Behcet Syndrome

KW - Dermatologic Agents

KW - Etanercept

KW - Humans

KW - Immunoglobulin G

KW - Immunologic Factors

KW - Infliximab

KW - Interferons

KW - Lymphoma, T-Cell, Cutaneous

KW - Pemphigus

KW - Pyoderma Gangrenosum

KW - Receptors, Tumor Necrosis Factor

KW - Rituximab

KW - Skin Diseases

KW - Skin Neoplasms

UR - https://www.scopus.com/pages/publications/45749086149

M3 - Tidsskriftartikel

C2 - 18565293

SN - 0041-5782

VL - 170

SP - 2126

EP - 2128

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 24

ER -

Biologiske behandlinger af andre dermatologiske sygdomme end psoriasis

Abstract

Other files and links

Fingerprint

Cite this